Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $542.97 thousand as of March 6, 2026. Its market cap has decreased by -65.60% in one year.

Market Cap

542.97K

Enterprise Value

1.33M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.10

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 542.97K, a decrease of -99.68%. That is a compound annual growth rate of -39.16%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	542.97K	2.71%
Dec 31, 2025	528.62K	40.64%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Avenue Therapeutics	583.48K
Bio-Path Holdings	552.12K
Windtree Therapeutics	595.61K
Aibotics	512.47K
Hepion Pharmaceuticals	499.67K
SQZ Biotechnologies Company	707.79K
Lipella Pharmaceuticals	716.69K
Scorpius Holdings	733.71K

Market Cap Rankings